Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema
Clinical trial NCT00306904 · COMPLETED
Trial details
- NCT number
- NCT00306904
- Sponsor
- OPKO Health, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2007-09-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.